Related Experiment Video
Updated: Jun 21, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
Cross-sectional analysis of chikungunya vaccine acceptability among residents of Ponce, Puerto Rico, 2024-2025
Sarah Anne J Guagliardo1, Chelsea G Major2, Dania M Rodriguez2
1Arboviral Diseases Branch, Division of Vector-borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
Abstract:
Chikungunya virus has previously caused outbreaks in U.S. territories. Recent chikungunya vaccine availability has expanded prevention options. We conducted a cross-sectional analysis of the acceptability of a hypothetical chikungunya vaccine provided at low or no cost among residents of Ponce, Puerto Rico. Among 2437 survey participants, 70.7% indicated they would get the vaccine, 22.6% would not, and 6.7% were unsure. Multivariable logistic regression showed that, after accounting for sex, vaccine acceptance was lower for participants aged 31-50 years (adjusted Odds Ratio [aOR]: 0.51, 95% confidence interval [CI]: 0.37-0.69) and > 50 years (aOR: 0.67, 95% CI: 0.47-0.95) compared with younger adults, and for people completing some higher education (aOR: 0.45, 95% CI: 0.26-0.78) compared with those with less than high school education. The most common reason for being uninterested or unsure was wanting to know about vaccine safety and side effects, emphasizing the importance of education and communication efforts to improve vaccine uptake.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Cross-reactivity
Vaccinations
Bioavailability Study Design: Healthy Subjects Versus Patients
Vaccines
Bias in Epidemiological Studies
